Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pergoveris 900IU Injection
Manufacturer/Marketed By : MERCK LTD
$365.83 $321.94
Pergoveris 900IU Injection contains two active components: follitropin alfa (a recombinant follicle-stimulating hormone) and lutropin alfa (a recombinant luteinizing hormone). It is a fertility medicine used to treat women with...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
FOLLITROPIN ALFA,LUTROPIN ALFA
Active Pharmaceutical Ingredient
Pergoveris 900IU Injection
365,83$
321,94$
Pergoveris 900IU Injection contains two active components: follitropin alfa (a recombinant follicle-stimulating hormone) and lutropin alfa (a recombinant luteinizing hormone). It is a fertility medicine used to treat women with infertility, especially those with low levels of natural reproductive hormones. This combination belongs to the gonadotropin group of hormones and works by stimulating the ovaries to promote the growth and development of healthy eggs. It is commonly prescribed for conditions like hypogonadotropic hypogonadism and is often used during assisted reproductive techniques like IVF. This medicine is given as a subcutaneous injection and should be used exactly as directed by your doctor to ensure safe and effective treatment.
Active Pharmaceutical Ingredient
Uses
• Treatment of female infertility caused by severe deficiency of LH and FSH (hypogonadotropic hypogonadism).
• Helps stimulate the growth and development of ovarian follicles in women who do not ovulate naturally.
• Used during assisted reproductive techniques (ART) like IVF (In-Vitro Fertilisation) to improve follicle development.
• Supports hormone balance in women with underactive pituitary function.
• Promotes ovulation in women who have not responded well to FSH treatment alone.
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Ovarian Hyperstimulation Syndrome (OHSS) — symptoms include severe abdominal pain, swelling, rapid weight gain, or shortness of breath.
• Blood clots — signs include leg pain or swelling, chest pain, or difficulty breathing.
• Allergic reactions — rash, itching, swelling of face/lips, or difficulty breathing.
• Ovarian cyst rupture (rare).
• Ectopic pregnancy (pregnancy outside the womb, rare but serious).
Common Side Effects
• Mild abdominal pain or bloating.
• Headache.
• Nausea.
• Breast tenderness.
• Injection site reactions (redness, swelling, or itching).
How To Use
Pergoveris 900IU Injection should be used exactly as prescribed by your doctor. This medicine is administered as a subcutaneous injection, meaning it is injected just under the skin, typically in the abdomen or thigh area. Your doctor or nurse will instruct you on how to properly prepare and administer the medicine if you plan to use it at home. The dose and duration of treatment depend on your medical condition and response to the therapy. Do not change the dose, skip doses, or stop the treatment without consulting your doctor. Regular monitoring with ultrasound and hormone tests may be done during treatment to check your response.
Safety Advice
• Pregnancy: Do not use this medicine if you are already pregnant. Stop treatment immediately if you become pregnant and inform your doctor.
• Breast Feeding: This medicine is not recommended during breastfeeding, as it is meant for women trying to conceive. Talk to your doctor if you are breastfeeding.
• Lungs: Pergoveris 900IU Injection typically does not have a direct effect on the lungs. However, in rare cases, serious side effects like fluid build-up in the abdomen or chest (pleural effusion) can occur as part of Ovarian Hyperstimulation Syndrome (OHSS). This may cause breathlessness, chest discomfort, or difficulty breathing.
• Liver: Use with caution if you have liver or kidney problems. Inform your doctor before starting treatment.
• Alcohol: It is advisable to limit or avoid alcohol while on this treatment, as it may affect hormone levels and reduce treatment success.
• Driving: This medicine is unlikely to affect your ability to drive or operate machines. However, some people may feel dizzy or tired—if this happens, avoid driving.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.